Metraipolis › archive › dc_12fb1bc66e17
Early post-approval experience of the selective cytopheretic device surveillance registry for pediatric AKI requiring kidney replacement therapy — Europe PMC PMID:41652244
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41652244
- DOI
- 10.1007/s00467-[numero omesso]-1
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T01:47:26.800Z
- SHA-256 of the archived text
df39f93697b4665d08f9b8a415dcb6bc346938a1b69a1540a5010023b4e482ae- Stable URL of this page
https://metraipolis.com/documento/dc_12fb1bc66e17
How to cite
Early post-approval experience of the selective cytopheretic device surveillance registry for pediatric AKI requiring kidney replacement therapy — Europe PMC PMID:41652244 — Europe PMC (en), https://europepmc.org/article/MED/41652244 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_12fb1bc66e17 (Metraipolis archive dc_12fb1bc66e17, sha256 df39f93697b4665d08f9b8a415dcb6bc346938a1b69a1540a5010023b4e482ae)
BibTeX
@misc{dc12fb1bc66e17,
title = {Early post-approval experience of the selective cytopheretic device surveillance registry for pediatric AKI requiring kidney replacement therapy — Europe PMC PMID:41652244},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41652244},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_12fb1bc66e17; sha256 df39f93697b4665d08f9b8a415dcb6bc346938a1b69a1540a5010023b4e482ae},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41652244. Agents can read the archived copy with the MCP tool read_document.